| Issue | Title | |
| Vol 2010, No 2 (2010) | Royalty Rates: Feeling Lucky | Abstract jpg |
| Taskin Ahmed | ||
| Vol 2012, No 7 (2012) | Russia’s SatRx Licenses Exclusive Rights to Pfizer’s DPP-IV Inhibitor | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 4 (2011) | RXi Pharmaceuticals Looks Beyond RNAi Therapeutics with Apthera Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2009, No 1 (2009) | S*Bio Signs Two Major Anticancer Deals | Abstract pdf html |
| Taskin Ahmed | ||
| Vol 2006, No 75 (2006) | Sales and Marketing | Details jpg |
| Business Review Editor | ||
| Vol 2013, No 11 (2013) | Salix Adds to Gastroenterology Franchise with US$2.6 B Santarus Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 11 (2011) | Salix Expands its Product Portfolio with US$300 M Oceana Therapeutics Buyout | Abstract |
| Heather Cartwright | ||
| Vol 2007, No 82 (2007) | Salix Expands Product Portfolio through Merck & Co. Licensing Deal | Abstract pdf |
| Business Review Editor | ||
| Vol 2014, No 8 (2014) | Salix Joins the Tax Inversion Wave by Agreeing to Merge with Cosmo Pharmaceuticals’ Irish Unit | Abstract |
| Heather Cartwright | ||
| Vol 2006, No 76 (2006) | Salix Licenses Right to Market and Distribute Sanvar® from Debiopharm | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 62 (2005) | Salix to Acquire InKine in Gastrointestinal Merger | Abstract pdf |
| Business Review Editor | ||
| Vol 2007, No 89 (2007) | Samples | Details jpg |
| Business Review Editor | ||
| Vol 2010, No 5 (2010) | Sandoz to acquire respiratory firm Oriel | Abstract |
| Taskin Ahmed | ||
| Vol 2018, No 1 (2018) | Sanofi Acquires Haemophilia Specialist Bioverativ for US$11.6 B | Abstract pdf html |
| Subham Nandi | ||
| Vol 2020, No 8 (2020) | Sanofi Acquires Principia for US$3.68 B | Abstract html pdf |
| Michelle Liu | ||
| Vol 2024, No 2 (2024) | Sanofi Acquires Rare Disease Developer Inhibrx for up to US$2.2 B | Abstract pdf html |
| Ashish Tripathi | ||
| Vol 2020, No 1 (2020) | Sanofi Adds Depth to its Pipeline with US$2.6 B Nurix Collaboration | Abstract html pdf |
| Subham Nandi | ||
| Vol 2017, No 5 (2017) | Sanofi and Exscientia to Develop Bispecific Molecules for Diabetes | Abstract pdf html |
| Jasmine Kalsi | ||
| Vol 2009, No 11 (2009) | Sanofi and Micromet Collaborate on Early Stage Cancer Antibody | Abstract |
| Taskin Ahmed | ||
| Vol 2022, No 11 (2022) | Sanofi and miRecule Partner to Develop Novel Antibody-RNA Conjugate for Muscular Dystrophy Therapy | Abstract pdf html |
| Swati Sharan | ||
| Vol 2023, No 10 (2023) | Sanofi and Teva to Collaborate on Inflammatory Bowel Disease Treatment | Abstract pdf html |
| Lalit Mishra | ||
| Vol 2016, No 9 (2016) | Sanofi and Verily form joint venture to Personalise Diabetes Care | Abstract pdf html |
| Jasmine Kalsi | ||
| Vol 2012, No 3 (2012) | Sanofi Augments its Biosurgery Unit with Pluromed Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2021, No 1 (2021) | Sanofi Bolsters Immunology Portfolio with US$1.45 B Kymab Acquisition | Abstract pdf html |
| Michelle Liu | ||
| Vol 2021, No 9 (2021) | Sanofi Bolsters Pipeline with Two Multibillion-Dollar Deals | Abstract pdf html |
| Neha Madhwani | ||
| Vol 2009, No 8 (2009) | Sanofi Boosts Vaccine Presence | Abstract |
| Taskin Ahmed | ||
| Vol 2023, No 3 (2023) | Sanofi Buys Provention Bio and its Type 1 Diabetes Drug for US$2.9 B | Abstract pdf html |
| Lucy Haggerty | ||
| Vol 2018, No 11 (2018) | Sanofi Collaborates with Denali for its RIPK1 Programme | Abstract pdf html |
| Michelle Liu | ||
| Vol 2012, No 9 (2012) | Sanofi Collaborates with Oncodesign to Develop Inhibitors of Challenging Kinase Targets | Abstract |
| Heather Cartwright | ||
| Vol 2022, No 10 (2022) | Sanofi Collaborates with Scribe Therapeutics in CRISPR Cell Therapy Deal | Abstract pdf html |
| Lucy Haggerty | ||
| Vol 2009, No 10 (2009) | Sanofi Continues its Buying Spree | Abstract |
| Taskin Ahmed | ||
| Vol 2018, No 6 (2018) | Sanofi Deepens Investment in mRNA Vaccines with Translate Bio Collaboration | Abstract pdf html |
| Heather Cartwright | ||
| Vol 2020, No 9 (2020) | Sanofi Delves Further into Protein Degrader Therapies with US$2.33 B Kymera Deal | Abstract pdf html |
| Ashish Tripathi & Michelle Liu | ||
| Vol 2022, No 3 (2022) | Sanofi Enters Multi-Billion Dollar Antibody Deals with Adagene and IGM | Abstract pdf html |
| Lucy Haggerty | ||
| Vol 2020, No 7 (2020) | Sanofi Expands mRNA Collaboration with Translate Bio | Abstract pdf html |
| Pratika Pahwa & Michelle Liu | ||
| Vol 2009, No 12 (2009) | Sanofi Inks Antibody Deals Targeting Infections and Alzheimer’s | Abstract |
| Taskin Ahmed | ||
| Vol 2012, No 10 (2012) | Sanofi Looks to Second-Generation Emerging Markets with Genfar Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2018, No 2 (2018) | Sanofi Makes Second Big Buy of the Month with Ablynx Acquisition | Abstract pdf html |
| Natasha Piper | ||
| Vol 2014, No 11 (2014) | Sanofi Pasteur Partners with Immune Design in Race to Develop First HSV-2 Vaccine | Abstract |
| Heather Cartwright | ||
| Vol 2024, No 9 (2024) | Sanofi Pays RadioMedix and Orano Med US$110 M Upfront for Radioligand Medicine | Abstract pdf html |
| Lucy Haggerty | ||
| Vol 2017, No 11 (2017) | Sanofi Signs Deal with Principia to Strengthen its Position in Multiple Sclerosis | Abstract pdf html |
| Natasha Piper | ||
| Vol 2015, No 12 (2015) | Sanofi Signs Trio of Deals to Bolster Diabetes and Oncology Pipelines | Abstract PDF html |
| Heather Cartwright & Rohit Khera | ||
| Vol 2022, No 11 (2022) | Sanofi Signs US$1.2 B AI Drug Discovery Deal with Insilico Medicine | Abstract pdf html |
| Lucy Haggerty | ||
| Vol 2016, No 4 (2016) | Sanofi Signs US$2.26 B Deal with Start-Up DiCE Molecules to Develop Next-Generation Oral Therapeutics | Abstract pdf html |
| Heather Cartwright & Natasha Berry | ||
| Vol 2022, No 7 (2022) | Sanofi Signs US$2.54 B Collaboration Deal with Skyhawk Therapeutics for RNA-splicing Modulators | Abstract pdf html |
| Ashish Tripathi | ||
| Vol 2009, No 4 (2009) | Sanofi to Acquire Brazilian Generics Firm | Abstract |
| Taskin Ahmed | ||
| Vol 2025, No 3 (2025) | Sanofi to Acquire Dren Bio’s Autoimmune Bispecific Antibody for US$1.9 B | Abstract pdf html |
| Lucy Haggerty | ||
| Vol 2019, No 12 (2019) | Sanofi Ups Immuno-oncology Investment with US$2.5 B Synthorx Buy | Abstract pdf html |
| Michelle Liu | ||
| Vol 2017, No 7 (2017) | Sanofi Ups its Game in Vaccines Market with US$750 M Acquisition of Protein Sciences | Abstract pdf html |
| Jawala Prasad | ||
| Vol 2010, No 9 (2010) | Sanofi-aventis Acquires BMP Sunstone to Strengthen its Chinese Consumer Healthcare Position | Abstract |
| Editorial Team | ||
| Vol 2010, No 7 (2010) | Sanofi-aventis Acquires TargeGen to Strengthen its Oncology Pipeline | Abstract |
| Staff Editor | ||
| Vol 2010, No 7 (2010) | Sanofi-aventis Advances Diabetes Pipeline | Abstract |
| Staff Editor | ||
| Vol 2010, No 6 (2010) | Sanofi-Aventis and Nichi-Iko Pharmaceutical in new joint venture | Abstract |
| Debbie Tranter | ||
| Vol 2009, No 11 (2009) | Sanofi-aventis and Regeneron Extend Therapeutic Antibody Agreement | Abstract |
| Taskin Ahmed | ||
| Vol 2009, No 4 (2009) | Sanofi-aventis Circles Solvay | Abstract |
| Taskin Ahmed | ||
| Vol 2010, No 7 (2010) | Sanofi-aventis Expands its Early-Stage Pipeline | Abstract |
| Heather Cartwright | ||
| Vol 2008, No 98 (2008) | Sanofi-Aventis Expands its Vaccine Portfolio | Abstract pdf html |
| Taskin Ahmed | ||
| Vol 2011, No 1 (2011) | Sanofi-aventis Forms Covalent Drug Discovery Partnership with Avila Therapeutics in Oncology | Abstract |
| Heather Cartwright | ||
| Vol 2010, No 7 (2010) | Sanofi-aventis Forms microRNA Alliance with Regulus Therapeutics | Abstract |
| Staff Editor | ||
| Vol 2008, No 100 (2008) | Sanofi-aventis Gains Zentiva With Sweeter Offer | Abstract html |
| Taskin Ahmed | ||
| Vol 2009, No 12 (2009) | Sanofi-Aventis Moves into US OTC Market | Abstract |
| Taskin Ahmed | ||
| Vol 2009, No 5 (2009) | Sanofi-aventis To Acquire BiPar Sciences | Abstract |
| Taskin Ahmed | ||
| Vol 2011, No 9 (2011) | Sanofi’s Aventis Pharma Subsidiary to Acquire Nutraceuticals Business of India’s Universal Medicare | Abstract |
| Heather Cartwright | ||
| Vol 2004, No 45 (2004) | Sanofi’s Hostile Bid for Aventis Rejected | Abstract pdf |
| Business Review Editor | ||
| Vol 2013, No 4 (2013) | Santaris Pharma Gains Another Collaborator in BMS | Abstract |
| Heather Cartwright | ||
| Vol 2014, No 2 (2014) | Santaris’ RNA-Targeting Platform Delivers Three Deals in Three Days | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 10 (2011) | Santen Pharmaceutical Strengthens its Ophthalmology Portfolio with Novagali Pharma Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2007, No 79 (2007) | Santhera Pharmaceuticals AG | Abstract |
| Business Review Editor | ||
| Vol 2006, No 68 (2006) | Satraplin | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 48 (2004) | Schering AG Agrees to Commercialise Praecis' Plenaxis™ | Abstract pdf |
| Business Review Editor | ||
| Vol 2003, No 33 (2003) | Schering AG to Market Campath® in South East Asia | Abstract pdf |
| Business Review Editor | ||
| Vol 2003, No 36 (2003) | Schering and Astex Enter Multi-target Drug Discovery Alliance | Abstract pdf |
| Business Review Editor | ||
| Vol 2002, No 27 (2002) | Schering-Plough Acquires Rights to Antibodies | Abstract |
| Business Review Editor | ||
| Vol 2007, No 83 (2007) | Schering-Plough and Merck & Co. to Develop new Cholesterol Treatment | Abstract pdf |
| Business Review Editor | ||
| Vol 2003, No 37 (2003) | Schering-Plough and Novartis: Newcomers to the Combination Market | Abstract |
| Business Review Editor | ||
| Vol 2007, No 82 (2007) | Schering-Plough in US$14.4 B Acquisition of Organon BioSciences | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 47 (2004) | Schering-Plough Licenses Toyama’s Antibacterial Agent | Abstract pdf |
| Business Review Editor | ||
| Vol 2002, No 30 (2002) | Schering-Plough to Distribute Novartis Asthma Product in US | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 57 (2005) | Schering’s and Novartis’ New Co-Promotion Agreement for PTK/ZK | Abstract pdf |
| Business Review Editor | ||
| Vol 2011, No 4 (2011) | SciClone Strengthens its Presence in China with NovaMed Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2009, No 11 (2009) | Sciele Buys Partner Addrenex | Abstract |
| Taskin Ahmed | ||
| Vol 2022, No 10 (2022) | Seagen Enters into License Agreement with Lava Therapeutics for LAVA-1223 | Abstract pdf html |
| Ashish Tripathi | ||
| Vol 2022, No 10 (2022) | Seagen Signs Collaboration and License Agreement with Zai Lab for Tivdak® | Abstract pdf html |
| Ayush Saxena | ||
| Vol 2009, No 12 (2009) | Seasons Greetings from PharmaVentures Ltd | Abstract jpg |
| Clive Goddard | ||
| Vol 2009, No 12 (2009) | Seattle Genetics and Agensys Expand Cancer Collaboration | Abstract |
| Taskin Ahmed | ||
| Vol 2013, No 7 (2013) | Seattle Genetics and Bayer Partner for a Second Time to Develop Antibody-Drug Conjugates | Abstract |
| Heather Cartwright | ||
| Vol 2007, No 80 (2007) | Seattle Genetics Boosts Cash Pile with January Deals | Abstract pdf |
| Business Review Editor | ||
| Vol 2018, No 2 (2018) | Seattle Genetics Strengthens Pipeline with Acquisition of Cascadian for US$614 M | Abstract pdf html |
| Arun Manohar | ||
| Vol 2009, No 5 (2009) | SEC Probes Schering-Plough Trades before Merck Deal | Abstract |
| Taskin Ahmed | ||
| Vol 2007, No 82 (2007) | Security | Details jpg |
| Business Review Editor | ||
| Vol 2005, No 55 (2005) | Seeking the 'Delta' | Details html |
| Fintan Walton | ||
| Vol 2012, No 12 (2012) | Selecta Biosciences Partners with Sanofi to Develop Antigen-Specific Immunotherapies for Allergies | Abstract |
| Heather Cartwright | ||
| Vol 2002, No 31 (2002) | Senetek Enters into Two Agreements in its Core Areas of Erectile Dysfunction and Skin Care | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 57 (2005) | Sepracor and ACADIA Forge CNS Alliance | Abstract pdf |
| Business Review Editor | ||
| Vol 2008, No 96 (2008) | Sepracor Enters into Multiple Deals with Arrow | Abstract pdf html |
| The PharmaDeals Team | ||
| Vol 2007, No 88 (2007) | Sepracor’s Insomnia Drug Enters Europe with GSK Deal | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 63 (2005) | Sereno and Genmab Partner Again with a US$215 M Deal | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 49 (2004) | Sereno SA | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 46 (2004) | Serono and InDex in Ulcerative Colitis Deal | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 55 (2005) | Serono and Nautilus Sign Hormone Agreement | Abstract pdf |
| Business Review Editor | ||
| 2101 - 2200 of 2581 Items | << < 17 18 19 20 21 22 23 24 25 26 > >> | |